Bank of Montreal
BBIO icon

Bank of Montreal’s BridgeBio Pharma BBIO Stock Holding History

Bank of Montreal’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
37,514
+1,343
+4% +$94.1K ﹤0.01% 1597
2026
Q1 		$2.69M Buy
36,171
+3,761
+12% +$273K ﹤0.01% 1545
2025
Q4 		$2.48M Buy
32,410
+20,635
+175% +$1.35M ﹤0.01% 1574
2025
Q3 		$612K Buy
11,775
+1,910
+19% +$93.2K ﹤0.01% 2179
2025
Q2 		$426K Buy
9,865
+556
+6% +$20.2K ﹤0.01% 2368
2025
Q1 		$322K Buy
9,309
+133
+1% +$4.49K ﹤0.01% 2469
2024
Q4 		$252K Buy
9,176
+277
+3% +$7.16K ﹤0.01% 2642
2024
Q3 		$222K Sell
8,899
-626
-7% -$16.4K ﹤0.01% 2976
2024
Q2 		$260K Buy
9,525
+825
+9% +$22.6K ﹤0.01% 2830
2024
Q1 		$269K Sell
8,700
-18
-0.2% -$612 ﹤0.01% 2851
2023
Q4 		$366K Sell
8,718
-5,890
-40% -$177K ﹤0.01% 2722
2023
Q3 		$427K Buy
+14,608
New +$415K ﹤0.01% 2559
2023
Q2 		– Sell
-13,880
Closed -$246K – 3975
2023
Q1 		$246K Buy
+13,880
New +$162K ﹤0.01% 2891
2022
Q3 		– Sell
-10,001
Closed -$90 – 4074
2022
Q2 		$90 Buy
10,001
+628
+7% +$5.25K ﹤0.01% 3480
2022
Q1 		$97K Sell
9,373
-111,087
-92% -$1.14M ﹤0.01% 3657
2021
Q4 		$1.76M Sell
120,460
-6,205
-5% -$263K ﹤0.01% 1653
2021
Q3 		$6.24M Buy
126,665
+35,626
+39% +$1.91M ﹤0.01% 1525
2021
Q2 		$5.48M Buy
91,039
+7,693
+9% +$439K ﹤0.01% 1565
2021
Q1 		$4.84M Buy
83,346
+71,714
+617% +$4.69M ﹤0.01% 1370
2020
Q4 		$798K Buy
11,632
+7,863
+209% +$379K ﹤0.01% 2396
2020
Q3 		$148K Sell
3,769
-2,313
-38% -$72.8K ﹤0.01% 2871
2020
Q2 		$196K Buy
6,082
+5,068
+500% +$154K ﹤0.01% 2745
2020
Q1 		$25K Sell
1,014
-2,832
-74% -$87.8K ﹤0.01% 3155
2019
Q4 		$135K Sell
3,846
-486
-11% -$13.5K ﹤0.01% 3365
2019
Q3 		$93K Sell
4,332
-5,668
-57% -$157K ﹤0.01% 3338
2019
Q2 		$270K Buy
+10,000
New +$273K ﹤0.01% 2766

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of Montreal's BBIO Position: Q2 2026 in Review

Bank of Montreal increased its BridgeBio Pharma (BBIO) stake by 3.7% in Q2 2026, buying an estimated $94.1K and bringing the position to 37,514 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Bank of Montreal first reported a position in BBIO in Q2 2019 and has held it in 26 quarters since. The position peaked at $6.24M in Q3 2021. 439 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Bank of Montreal held 37,514 shares of BridgeBio Pharma worth $2.79M as of Q2 2026.
  • Bank of Montreal bought 1,343 BridgeBio Pharma shares in Q2 2026, an estimated $94.1K.
  • BridgeBio Pharma made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1597 holding.
  • Bank of Montreal first reported a position in BridgeBio Pharma in Q2 2019 and has held it in 26 quarters since.
  • Bank of Montreal's BridgeBio Pharma position peaked at $6.24M in Q3 2021.
  • 439 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.